What Gross Margin Does a HealthTech Business Have?
HealthTech businesses typically achieve gross margins of 75% to 87% on B2B SaaS models and 50% to 65% on direct-to-consumer clinical offerings. Revenue Map's healthtech presets model per-seat COGS of $22 at launch against a $90 seat price, implying seat-level margin near 76%, improving to 87% by Phase 3 as COGS drops to $15 against a $115 price.
Gross margin in healthtech measures what remains of each revenue dollar after the direct costs of delivering the service: hosting, clinical infrastructure, third-party API fees, and per-patient delivery costs. It excludes compliance spend, sales, marketing, and R&D, though compliance costs often get conflated with COGS in early-stage reporting and artificially depress the number. Separating true COGS from compliance overhead is the first step toward understanding the real unit economics.
The distinction matters because healthtech spans radically different delivery models. A B2B SaaS platform selling to hospitals carries software-like COGS of $15 to $22 per seat, while a telehealth service delivering clinical sessions carries therapist or clinician time, malpractice insurance, and platform fees that push COGS to 35-50% of revenue. Revenue Map's presets capture this split across engines: the SaaS engine models seat-level margins of 76-87%, while the subscription engine carries 20-25% COGS on monthly pricing.
Revenue Breakdown
HealthTech gross margin ranges by model type and stage
| Item | Typical range | Notes | Source |
|---|---|---|---|
| B2B per-seat model (Phase 1) | About 76% | $90 per seat less $22 COGS per seat at launch | Revenue Map model presets |
| B2B per-seat model (Phase 3) | About 87% | $115 per seat less $15 COGS per seat at scale | Revenue Map model presets |
| Subscription model (patient-facing) | 75% to 80% | Preset COGS of 20-25% on $39.99 to $49.99 monthly pricing | Revenue Map model presets |
| DTC telehealth (clinical delivery) | 50% to 65% | Clinician time, malpractice, and platform fees push COGS well above software-only levels | Industry range |
| Compliance drag on net margin | 15% to 25% of early spend | HIPAA, SOC 2, clinical validation; OpEx, not COGS, but compresses net margin | Revenue Map model templates |
| Reimbursement realization (payer models) | 40% to 70% of billed | Effective revenue is collected, not billed; payer mix drives the gap | Revenue Map model templates |
Sources: Revenue Map model presets (default investment, pricing and funnel assumptions in our industry templates), Revenue Map model templates (vertical research in each financial model), Revenue Map benchmark tables (the thresholds behind our free calculators), and honest industry ranges where our own data is thin. Ranges are planning bands, not guarantees.
What Moves the Number
Model type determines the margin band
A B2B SaaS platform and a DTC telehealth service both count as healthtech, but they sit in entirely different margin bands. Revenue Map's SaaS engine models $22 COGS per seat against $90 pricing (76% margin), while clinical delivery models carry 35-50% COGS from therapist time and insurance. Knowing which model you are running is the prerequisite to knowing whether your margin is healthy.
Compliance is OpEx, not COGS, but it compresses net margin
HIPAA infrastructure, SOC 2 audits, and clinical validation absorb 15-25% of early-stage spend. These are not cost of goods, so they do not reduce gross margin, but they sit between gross margin and the net margin that actually reaches the bank. A healthtech company showing 80% gross margin and 25% compliance drag has roughly 55% of revenue left before sales, marketing, and R&D.
Scale improves margin on both lines
Revenue Map's presets show COGS per seat declining from $22 to $15 across growth phases as infrastructure amortizes across more customers. Compliance also scales favorably: the presets carry $5,000 per month of regulatory misc costs, which shrinks as a percentage of revenue as the customer base grows. Both effects push margin upward with scale.
Reimbursement models reduce effective revenue
If insurers pay, collected revenue is often only 40-70% of billed charges. A healthtech company billing $100 per patient visit but collecting $60 effectively has 40% lower revenue than its price suggests, which inflates the apparent COGS-to-revenue ratio even if true delivery costs have not changed. Model on collected revenue, not billed.
Frequently Asked Questions
What is a good gross margin for healthtech?
Why does healthtech margin vary so much?
Does compliance reduce gross margin?
How does healthtech gross margin compare to SaaS?
Go Deeper
Benchmarks
What would your numbers look like?
These are honest ranges, but your business is specific. Revenue Map turns your own assumptions into a 36-month projection with break-even, burn and runway in about five minutes.
Model your exact numbers free